The arithmetic at Ubtech Robotics is becoming harder to argue with. First-half 2026 revenue hit 1.269 billion renminbi, up 104.2 percent year on year, and the company’s full-size humanoid segment — long a showcase of engineering ambition rather than commercial heft — delivered 590 million renminbi in sales, a 1,445 percent explosion that made it the group’s single largest revenue line at a 46.5 percent share. Some 16,123 humanoid units moved in the period, 921 of them from the full-size range.
Yet the equity market has stubbornly refused to join the celebration. The stock closed Thursday at 8.90 euros, down 0.8 percent on the day, and sits roughly 38 percent below its level at the start of the year. Against the 52-week high of 17.00 euros touched in mid-January, the shares are off 48 percent — hovering just a few percentage points above the late-July trough. Friday brought some relief, with the shares jumping 6.1 percent to 9.45 euros as investors digested the results, but the broader trajectory remains deeply negative.
Margin Gains and a Shrinking Loss
Beneath the headline growth, the quality of earnings is improving. Gross profit climbed 160.9 percent to 567 million renminbi, lifting the gross margin by 970 basis points to 44.7 percent. The net loss narrowed 23.0 percent to 339 million renminbi, while the adjusted EBITDA deficit shrank by 45.9 percent. The company remains loss-making, but the burn rate is visibly decelerating — a sign that heavy upfront investment in production capacity is beginning to pay off.
Ubtech plowed more than 300 million renminbi into research and development during the period and employs 1,103 engineers, underscoring the extent to which this remains a technology bet as much as a manufacturing one.
A Product Pipeline With Real Order Books
The growth story gained tangible momentum at the World Robot Conference in late August, where Ubtech unveiled its new U1 series. Management reports more than 13,000 orders already booked through distribution channels, with first deliveries scheduled for September 16. The same event showcased the Cruzr Y1 and Cruzr S2 industrial robots, already deployed in customer production lines for tasks including auto-part handling and logistics sorting.
The U1 launch represents a critical test: whether the company can translate conference-floor enthusiasm into sustained consumer demand. The order book is encouraging, but execution risk remains — a point that sector observers have been keen to stress.
Supply-Chain Fortification
Ubtech has also been busy securing its technological foundations. Mid-August brought a strategic cooperation agreement with semiconductor maker BASiC Semiconductor, focused on silicon-carbide power components for humanoid robots. The logic is straightforward: onboard voltages are expected to rise from the current 48 volts to 96 volts and eventually 400 volts, and silicon-carbide devices offer the voltage tolerance and heat resistance that transition will demand. Ubtech’s robots, in turn, will be deployed on BASiC’s own production lines.
Should investors sell immediately? Or is it worth buying Ubtech Robotics?
The arrangement dovetails with another strategic move — the completed acquisition of a 43.01 percent stake in Fenglong Shares, giving Ubtech control of the company. Fenglong’s financial results have been consolidated into Ubtech’s accounts since April 2026.
A separate memorandum of understanding with Singtel aims to develop enterprise robotics applications, combining Ubtech’s hardware with Singtel’s 5G network infrastructure and corporate customer base.
The Valuation Conundrum
CICC reaffirmed its buy recommendation on the stock in late August, though without setting a new price target. The endorsement reflects a broadly positive institutional view of the company’s growth trajectory — but it has yet to move the needle meaningfully on valuation.
Part of the caution stems from the sector itself. Reuters has noted that China’s humanoid robotics market, despite visible technological progress, remains constrained by limited practical utility in everyday applications. That assessment provides essential context: Ubtech’s revenue numbers are genuinely impressive, but the path to sustainable profitability across the entire sector remains an open question.
For now, the company’s immediate challenge is whether September’s U1 deliveries can carry first-half momentum into the second half — and whether the market will eventually reward operational progress with something more than a single-day bounce. The gap between the company’s operational trajectory and its share price performance is unlikely to close without sustained evidence that the humanoid boom can translate into dependable, recurring profit.
Ad
Ubtech Robotics Stock: Buy or Sell?! New Ubtech Robotics Analysis from September 4 delivers the answer:
The latest Ubtech Robotics figures speak for themselves: Urgent action needed for Ubtech Robotics investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from September 4.
Ubtech Robotics: Buy or sell? Read more here...
